US Patent 10092631 Methods for treating headache
Patent 10092631 was granted and assigned to Allergan, Inc. on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+397 characters)
Article
Patent abstract
A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Catherine C. Turkel0
Mitchell F. Brin0
Edits on 24 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 28 Jan, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10092631 Methods for treating headache
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10092631
Date of patent
October 9, 2018
Patent application number
15412392
Date Filed
January 23, 2017
Patent primary examiner
Find more entities like US Patent 10092631 Methods for treating headache
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
